RENAL TRANSPLANTATION

This study tested a new combination of drugs—siplizumab plus belatacept and mycophenolic acid—in 76 people who just received a kidney transplant. The goal was to see if this combo is safer and works better than the standard immunosuppression therapy. Researchers measured side eff…

This early-stage study tested a new approach to help kidney transplant recipients stop taking anti-rejection drugs. Eight adults received donor stem cells along with a special mix of medications to see if their bodies would accept the new kidney without needing lifelong drugs. Th…

This study tested whether a routine biopsy three months after kidney transplant can help doctors personalize immunosuppressive therapy. 346 patients were split into two groups: those with mild inflammation received extra steroids, while those with no inflammation had their steroi…

This study looked at whether the usual vitamin D supplement given to children with chronic kidney disease, kidney transplants, or nephrotic syndrome works well. 43 children received a single high-dose vitamin D vial, and doctors checked their vitamin D levels two months later. Th…

This study tested whether using sevoflurane (a gas for anesthesia) during kidney transplant surgery helps the new kidney start working faster compared to the standard drug propofol. About 120 adults receiving a kidney transplant took part. The goal was to see if sevoflurane could…

This study looked at two types of exercise—whole body vibration and aerobic training—in 60 adults who had a kidney transplant. The goal was to see which one better improved endurance and reduced a marker of inflammation called interleukin-6. Participants were between 30 and 45 ye…

This study looked at 128 kidney transplant patients with chronic graft dysfunction and anemia. Researchers compared two different hemoglobin levels to see which one better improved quality of life after 6 months and slowed kidney function decline over 24 months. The goal was to f…

This study involved 45 adults who received a kidney transplant. Researchers wanted to learn more about how the drug Advagraf (a prolonged-release form of tacrolimus) works in the body right after transplant and three months later. The goal was to find better ways to determine the…

This study explored whether analyzing the fluid used to preserve donor kidneys on a special machine can help predict how well the kidney will work after transplant. Researchers measured substances in the fluid and compared them to how the kidney functioned in the first week after…